654 results for "krytan tek side effects"

Search for:

Date Range to

654 Results on GlaucomaToday.com

April 2017April 2017

The Literature By Darrell WuDunn, MD, PhD, and Joshua W. Evans, MD

Highlights of the AGS Annual Meeting The latest results of clinical trials and research studies presented at the 27th Annual Meeting of the American Glaucoma Society, held March 2 to 5, 2017, in Coronado, California.
By Ambika Hoguet, MD, and Lucy Q. Shen, MD

Where We Are Today With MIGS With Leon W. Herndon, MD; Oluwatosin U. Smith, MD; Mahmoud A. Khaimi, MD; Sameh Mosaed, MD; Michael D. Greenwood, MD; Steven R. Sarkisian Jr, MD; Michael Berlin, MD, MS; Vigan Roka, MD; Michael Riggs; and Ulrich Giers, MD; Steven D. Vold, MD; Marc Töteberg-Harms, MD, FEBO; Erik L. Mertens, MD, FEBOphth, and Howard Barnebey, MD

Research Update on Laser Trabeculoplasty A literature search reveals interesting findings from 2016.
By Tony Realini, MD, MPH

A Targeted Approach Endocyclophotocoagulation for glaucoma management.
By Chungkwon Yoo, MD, PhD, and Shan C. Lin, MD

Cyclophotocoagulation Controversy Using this treatment option earlier in the disease course and in sighted eyes.
By James Fox, MD

The Role of Surgery A blueprint for treatment.
By Edward S. Yung, MD, and Marlene R. Moster, MD

New Diagnostic Tools OCT angiography, PERG, and corneal hysteresis.
By Jonathan S. Myers, MD

February 2017February 2017

The Literature By David L. Phillips, MD, and Norman A. Zabriskie, MD

The Role of Perfusion Pressure Risk factors other than IOP play a role in the pathogenesis of glaucoma.
By Robert N. Weinreb, MD; Jeffrey M. Liebmann, MD; and Louis R. Pasquale, MD

Point/Counterpoint: Has a Replacement for Trabeculectomy Finally Arrived? By Davinder S. Grover, MD, MPH, and Steven J. Gedde, MD

Journey to the Cutting Edge Nonaccredited ophthalmology meetings preview the future.
By Larissa Camejo, MD

A Case of Pediatric Sturge-Weber Syndrome The steps that saved the vision of a 3-year-old girl.
By Jayasree Venugopal, MS, MBBS

December 2016December 2016

Fixed Combinations A mainstay of glaucoma management today and tomorrow.
By Robert D. Fetchner, MD, and Albert S. Khouri, MD

Preservative-Free Alternatives Options for decreasing ocular toxicity in patients with glaucoma.
By Arkadiy Yadgarov, MD, and Reena A. Garg, MD

On The Horizon New medications give fresh hope for treating glaucoma.
By Jason Bacharach, MD

Sustained-Release Drug Delivery: the Future of Glaucoma Treatment Several devices are being investigated.
By Justin A. Schweitzer, OD, FAAO, and Mitch Ibach, OD, FAAO

Industry News

Phaco-Goniosynechialysis: Tap, Sweep, and Tweep By Jonathan S. Myers, MD

From the Trenches What is maximal medical therapy today? Three physicians share their thoughts.
By Howard Barnebey, MD; Carla J. Siegfried, MD; and Julia Song, MD

The Adherence Problem Its scope and strategies for its reduction.
By Henry D. Jampel, MD, MHS

Glaucoma in the Octogenarian Considerations in treating the advanced elderly.
By Samuel P. Solish, MD

The Literature By Jonathan Paul, MD, and Sheila Sanders, MD

October 2016October 2016

Cataract Surgery Alone—an Underused Solution? One of the most common ophthalmic surgical tools achieves more than its primary intended purpose.
By Nicholas Bell, MD

Suprachoroidal Access: the Next Big Thing? This new class of devices will allow further customization of glaucoma therapy.
By Cynthia Mattox, MD

Gonioscopy Is Essential for MIGS This critical skill set comprises more than docking the goniolens.
By Shakeel Shareef, MD

Tools of the Trade Instruments essential to any successful trabeculectomy.
By Jon M. Ruderman, MD, and Sara R. Ghobraiel, MD

MIGS in Kids Recent advances may reshape the traditional paradigm.
By Ta Chen Peter Chang, MD

Industry News

The Results Are in: 2016 Film Festival Winner Announced Congratulations to Shakeel Shareef, MD, the winner of the GT 2016 Film Festival.

To the FDA With Appreciation By Steven D. Vold, MD

August 2016August 2016

The Literature By Leonard K. Seibold, MD; Malik Y. Kahook, MD; and Jeffrey R. SooHoo, MD

What Is the Real IOP? Laboratory studies may help us better understand our clinical dilemmas.
By Dan Eisenberg, MD

Highlights of the 2016 ARVO Annual Meeting Select research findings presented this year.
By Sze H. Wong, MD, and Albert S. Khouri, MD

News Feature: a New Option for Uveitis Adalimumab, a rheumatology drug, offers hope to patients with this damaging inflammatory eye disease.
By Agustin L. Gonzalez, OD

Glaucoma After Corneal Limbal Stem Cell Transplantation By Ahmad A. Aref, MD; Kavitha R. Sivaramen, MD; and Ali R. Djalilian, MD

Foundations of a Great Physician By Linda Huang, MD

Ocular Surface Disease: Impact on Glaucoma Surgical Decision Making The preoperative planning process is more complex and requires careful attention to the unique issues at play.
By Tony Realini, MD, MPH

The Dark Side of Medication Many systemic and topical drugs can cause or worsen dry eye disease.
By Sarah Marshall, PhD, and Robert Noecker, MD, MBA

Tear Osmolarity in a Glaucoma Practice The role of point-of-care testing in dry eye disease and glaucoma management.
By Leslie E. O’Dell, OD

1234567891011121314151617 | Next >